Patch to treat Parkinson's gets FDA green light

NewsGuard 100/100 Score

The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.

The Rotigotine Transfermal System, also known as Neupro, is designed to treat the early symptoms of Parkinson's disease.

The patch is meant to be applied once each day and comes in three different strengths, 2mg, 4mg, and 6mg, depending on the severity of the symptoms; each patch will be effective for 24 hours.

The active ingredient in the rotigotine patch replicates the actions of dopamine which keeps motor functions working properly.

The FDA says common side effects for Neupro included skin reactions at the patch site, dizziness, nausea, vomiting, drowsiness and insomnia, which are common with this class of drugs.

There are 4 million people worldwide suffering from Parkinson's with 1 million alone in the U.S.

As most suffer from a lack of dopamine, this patch could remedy that deficiency.

Neupro is manufactured by Schwarz Bioscience and is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease; it is already approved for use in Europe.

The FDA approval for Neupro was based on a study involving 1,154 patients who had early signs of Parkinson's and had not begun any treatment.

The disease causes muscle rigidity, stiffness and tremors.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How can food influence the severity of menopausal hot flashes?